Example: Heart Attack

Clinical Trials on Chemotherapy-Induced Febrile Neutropenia

Total 17 results

NCT04000711

Completed

Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia

Conditions: Chemotherapy-Induced Febrile Neutropenia
NCT01813721

Completed

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Conditions: Chemotherapy-induced Febrile Neutropenia
NCT02178475

Completed

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Conditions: Chemotherapy-induced Febrile Neutropenia
NCT02956967

Completed

Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

Conditions: Non-Interventional Study
NCT02428114

Completed

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Conditions: Early Stage Breast Cancer
NCT02467868

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Conditions: Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia
NCT01574235

Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Conditions: Solid Tumors; Malignant Hemopathy; Chemotherapy-induced Febrile Neutropenia (FN)
NCT03823950

Recruiting

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

Conditions: Granulocyte Colony-Stimulating Factor; Chemotherapy-induced Neutropenia; Chemotherapy-Induced Febrile Neutropenia; Pediatric Cancer
NCT04460079

Completed

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Conditions: Chemotherapy-induced Neutropenia
NCT01459653

Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Conditions: Febrile Neutropenia; Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Prostate Cancer; Multiple Myeloma; Bladder Cancer; B-cell Lymphoma
NCT02816164

Completed

A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

Conditions: Early Stage Breast Cancer
NCT00003739

Completed

Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy

Conditions: Fever, Sweats, and Hot Flashes; Neutropenia; Unspecified Childhood Solid Tumor, Protocol Specific
NCT04101760

Recruiting

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

Conditions: Chemotherapy-induced Neutropenia; Febrile Neutropenia, Drug-Induced; Epithelial Ovarian Cancer; Colony Stimulating Factors Adverse Reaction; Granulocyte Colony Stimulating Factor; Cost-effectiveness Analysis; Quality of Life; Progression-free Survival; Overall Survival
NCT03182465

Recruiting

Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia

Conditions: Febrile Neutropenia, Drug-Induced
NCT03104595

Unknown status

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Conditions: Febrile Neutropenia
NCT03793205

Unknown status

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Conditions: Gynecologic Cancer; Myelosuppression Adult; Febrile Neutropenia; Chemotherapy-induced Neutropenia
NCT04134429

Completed

Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy

Conditions: Pediatric Cancer; Febrile Neutropenia; Chemotherapy-induced Neutropenia; Oncology